513 related articles for article (PubMed ID: 35950852)
1. Efficient Cas9-based Genome Editing Using CRISPR Analysis Webtools in Severe Early-onset-obesity Patient-derived iPSCs.
Patel A; Iannello G; Diaz AG; Sirabella D; Thaker V; Corneo B
Curr Protoc; 2022 Aug; 2(8):e519. PubMed ID: 35950852
[TBL] [Abstract][Full Text] [Related]
2. Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.
Yumlu S; Stumm J; Bashir S; Dreyer AK; Lisowski P; Danner E; Kühn R
Methods; 2017 May; 121-122():29-44. PubMed ID: 28522326
[TBL] [Abstract][Full Text] [Related]
3. Generating CRISPR-Cas9-Mediated Null Mutations and Screening Targeting Efficiency in Human Pluripotent Stem Cells.
Bower OJ; McCarthy A; Lea RA; Alanis-Lobato G; Zohren J; Gerri C; Turner JMA; Niakan KK
Curr Protoc; 2021 Aug; 1(8):e232. PubMed ID: 34432381
[TBL] [Abstract][Full Text] [Related]
4. A Robust Protocol for CRISPR-Cas9 Gene Editing in Human Suspension Cell Lines.
Wardyn JD; Chan ASY; Jeyasekharan AD
Curr Protoc; 2021 Nov; 1(11):e286. PubMed ID: 34748280
[TBL] [Abstract][Full Text] [Related]
5. Simple CRISPR-Cas9 Genome Editing in Saccharomyces cerevisiae.
Laughery MF; Wyrick JJ
Curr Protoc Mol Biol; 2019 Dec; 129(1):e110. PubMed ID: 31763795
[TBL] [Abstract][Full Text] [Related]
6. Use of single guided Cas9 nickase to facilitate precise and efficient genome editing in human iPSCs.
Li PP; Margolis RL
Sci Rep; 2021 May; 11(1):9865. PubMed ID: 33972655
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-Mediated Gene Knockout and Knockin Human iPSCs.
Petazzi P; Menéndez P; Sevilla A
Methods Mol Biol; 2022; 2454():559-574. PubMed ID: 33190185
[TBL] [Abstract][Full Text] [Related]
8. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.
Paquet D; Kwart D; Chen A; Sproul A; Jacob S; Teo S; Olsen KM; Gregg A; Noggle S; Tessier-Lavigne M
Nature; 2016 May; 533(7601):125-9. PubMed ID: 27120160
[TBL] [Abstract][Full Text] [Related]
9. Gene Editing in Human Induced Pluripotent Stem Cells Using Doxycycline-Inducible CRISPR-Cas9 System.
Thamodaran V; Rani S; Velayudhan SR
Methods Mol Biol; 2022; 2454():755-773. PubMed ID: 33830454
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9-Mediated Genome Editing to Generate Clonal iPSC Lines.
Sanjurjo-Soriano C; Erkilic N; Mamaeva D; Kalatzis V
Methods Mol Biol; 2022; 2454():589-606. PubMed ID: 33755901
[TBL] [Abstract][Full Text] [Related]
11. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.
Wang G; Yang L; Grishin D; Rios X; Ye LY; Hu Y; Li K; Zhang D; Church GM; Pu WT
Nat Protoc; 2017 Jan; 12(1):88-103. PubMed ID: 27929521
[TBL] [Abstract][Full Text] [Related]
12. Efficient Multi-Allelic Genome Editing of Primary Cell Cultures via CRISPR-Cas9 Ribonucleoprotein Nucleofection.
Hoellerbauer P; Kufeld M; Paddison PJ
Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e126. PubMed ID: 32833346
[TBL] [Abstract][Full Text] [Related]
13. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
Yumlu S; Bashir S; Stumm J; Kühn R
Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-Based Genome Editing of Transcription Factor Genes in Marchantia polymorpha.
Sugano SS; Nishihama R
Methods Mol Biol; 2018; 1830():109-126. PubMed ID: 30043367
[TBL] [Abstract][Full Text] [Related]
15. Ex Vivo Expansion and CRISPR-Cas9 Genome Editing of Primary Human Natural Killer Cells.
Huang RS; Lai MC; Lin S
Curr Protoc; 2021 Sep; 1(9):e246. PubMed ID: 34529358
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas9-Guided Genome Engineering in Caenorhabditis elegans.
Kim HM; Colaiácovo MP
Curr Protoc Mol Biol; 2019 Dec; 129(1):e106. PubMed ID: 31763794
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9 Genome Editing in the Moss Physcomitrium (Formerly Physcomitrella) patens.
Wu SZ; Ryken SE; Bezanilla M
Curr Protoc; 2023 Apr; 3(4):e725. PubMed ID: 37021953
[TBL] [Abstract][Full Text] [Related]
18. Editing the Genome of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes.
Bruntraeger M; Byrne M; Long K; Bassett AR
Methods Mol Biol; 2019; 1961():153-183. PubMed ID: 30912046
[TBL] [Abstract][Full Text] [Related]
19. Correction of Hemoglobin E/Beta-Thalassemia Patient-Derived iPSCs Using CRISPR/Cas9.
Wattanapanitch M
Methods Mol Biol; 2021; 2211():193-211. PubMed ID: 33336279
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas9 Genome Editing and Rapid Selection of Cell Pools.
Stoyko D; O T; Hernandez A; Konstantinidou P; Meng Q; Haase AD
Curr Protoc; 2022 Dec; 2(12):e624. PubMed ID: 36546759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
